GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ablynx NV (XBRU:ABLXS) » Definitions » YoY Rev. per Sh. Growth

Ablynx NV (XBRU:ABLXS) YoY Rev. per Sh. Growth : -33.92% (As of Dec. 2017)


View and export this data going back to . Start your Free Trial

What is Ablynx NV YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Ablynx NV's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2017 was -33.92%.

Ablynx NV's Revenue per Share for the six months ended in Dec. 2017 was €0.49.


Ablynx NV YoY Rev. per Sh. Growth Historical Data

The historical data trend for Ablynx NV's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ablynx NV YoY Rev. per Sh. Growth Chart

Ablynx NV Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
YoY Rev. per Sh. Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 29.30 43.87 60.81 10.48 -34.48

Ablynx NV Semi-Annual Data
Dec07 Dec08 Jun09 Dec09 Jun10 Dec10 Jun11 Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 49.83 39.68 -18.35 -34.74 -33.92

Ablynx NV YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Ablynx NV's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2017 is calculated as:

YoY Rev. per Sh. Growth (A: Dec. 2017 )
=(Revenue per Share (A: Dec. 2017 )-Revenue per Share (A: Dec. 2016 ))/ | Revenue per Share (A: Dec. 2016 ) |
=(1.271-1.94)/ | 1.94 |
=-34.48 %

Ablynx NV's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2017 is calculated as:

YoY Rev. per Sh. Growth (Q: Dec. 2017 )
=(Revenue per Share (Q: Dec. 2017 )-Revenue per Share (Q: Dec. 2016 )) / | Revenue per Share (Q: Dec. 2016 )) |
=(0.485-0.734)/ | 0.734 |
=-33.92 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ablynx NV YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Ablynx NV's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Ablynx NV (XBRU:ABLXS) Business Description

Traded in Other Exchanges
N/A
Address
Ablynx NV is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. It has 45 proprietary and partnered programs in development in various therapeutic areas including inflammation, hematology, immuno-oncology, oncology and respiratory disease. It has collaborations with multiple pharmaceutical companies including AbbVie; Boehringer Ingelheim; Eddingpharm; Merck & Co., Inc., Kenilworth, New Jersey, USA; Merck KGaA; Novartis; Novo Nordisk; Sanofi and Taisho Pharmaceuticals. The company generates revenue from research collaboration agreements and from government grants.

Ablynx NV (XBRU:ABLXS) Headlines

No Headlines